US 11,299,760 B2
USE OF MONENSIN TO REGULATE GLYCOSYLATION OF RECOMBINANT PROTEINS
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

US 11,299,760 B2
USE OF MONENSIN TO REGULATE GLYCOSYLATION OF RECOMBINANT PROTEINS
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Michail A Belyavskyi
Art Unit:
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
Agent:
Henry P. Wu
Inventors:
Mirna MUJACIC; Sandhya PANDE
Assignee:
Priority:
10/30/14
Filed:
09/01/21
Granted:
04/12/22
Expiration:
10/31/33
Cooperative Patent Classification (CPC)
C12C12P21/005C12P

Analytics

Cases

Patent Assignments

Citations